Vitamin E is a term encompassing a group of lipid-soluble, chain-breaking antioxidants that include ␣ -,  -, ␥ -, and ␦ -tocopherol and the corresponding tocotrienols (1). Vitamin E differs from other fat-soluble vitamins in that it is not accumulated in the liver to toxic levels during times of excess intake (1). A high rate of vitamin E metabolism and/or excretion may be important in preventing adverse effects (2), but this hypothesis has not yet been tested. Tocopherols and tocotrienols are not only excreted directly but can be metabolized in the liver by hepatocytes (3-5); other tissues involved in vitamin E metabolism have not been specifically identified.␣ -and ␥ -tocopherols are converted to their respective carboxyethyl hydroxychroman (CEHC) derivatives, ␣ -CEHC [2,5,7,8-tetramethyl-2-(2 Ј -carboxyethyl)-6-hydroxychroman] and ␥ -CEHC [2,7,8-trimethyl-2-(2 Ј -carboxyethyl)-6-hydroxychroman] ( Fig. 1 ). The specific steps involved in vitamin E metabolism have been identified in vitro using HepG2 cells. These steps initially involve -oxidation by cytochrome P450 enzymes followed by  -oxidative degradation (3, 4, 6).To evaluate in vivo metabolism of tocopherols, metabolite concentrations have been measured in human urine (5, 7-13), human plasma (5,(13)(14)(15)(16)(17)(18)(19), and rat bile (20,21). Recently, CEHCs have been reported to have potential health benefits (22-25) as well as antioxidant functions (26,27). These latter functions are questionable because of the extremely low CEHC concentrations in human plasma (14,15,18,22). There have also been discussions of the use of metabolite concentrations found in urine and plasma as indicators of vitamin E status (7,8,14,28,29), but, as this area is still fairly new and evolving, there is no clear evidence to support the use of metabolites as vitamin E status indicators.To our knowledge, there are no reports on tissue metabolite concentrations. Based on tissue culture studies of metabolite formation by hepatocytes (3-5), it is likely that CEHCs are produced in the liver. Therefore, we have deAbbreviations: CEHC, carboxyethyl hydroxychroman; LC-MS, liquid chromatography-mass spectrometry; MDR1, multidrug resistance protein-1; m/z , mass-to-charge ratio; SXR, steroid and xenobiotic receptor; UGT1A1, UDP-glucuronosyltransferase-1A1.